HATFIELD, Pa. — Biolyst Scientific, a leading provider of innovative solutions in the life sciences and clinical laboratory markets, is pleased to announce the appointment of Jay Hexamer as its new Chief Executive Officer (CEO), effective immediately. This leadership transition reflects Biolyst Scientific’s continued focus on innovation and market expansion. With more than 30 years of experience in […]
The Hettich Group is embarking on a new era of leadership as it restructures its management team for long-term growth and innovation. After two decades of successful leadership by the Eberle family, the company is implementing a forward-looking realignment set to take effect on April 1, 2025. A strong leadership team for the future The newly […]
Limula appoints cell therapy expert, Dr. Jonathan Esensten, to its Strategic Advisory Board. The appointment supports the development of LimONE, Limula’s integrated platform for automated cell and gene therapy (CGT) manufacturing. Lausanne, Switzerland – Limula, an emerging life science tools company specializing in automated Cell and Gene Therapy manufacturing solutions, has appointed Dr. Jonathan Esensten to […]
Mr. Jeffrey Gatz Brings Track Record of Growing companies and expertise in the Life Science Tools spaceg. WEST SACRAMENTO, Calif. — Gemini Bioproducts, LLC (“GeminiBio”), a biopharma and advanced therapy raw materials supplier, and a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a Fort Lauderdale-based healthcare private equity firm, announced today the appointment of Jeffrey Gatz to its […]
FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Gregory J. Hayes to its board of directors, effective March 26, 2025. BD appoints Gregory J. Hayes to its board of directors. Hayes, 64, is currently the executive chairman of the board of […]
MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced Jim Gibson will join and be appointed as the company’s new Chief Financial Officer, effective as of his start date, which is expected to be March 31, 2025. With over three decades of financial leadership experience at some […]
Christian Uhrich, Investment Director at M Ventures, joins Vizgen Board of Directors; Chad Brown joins the company as Chief Commercial Officer CAMBRIDGE, Mass. — Vizgen, Inc., the life sciences company revolutionizing spatial genomics research and driving innovation in spatial multi-omics, today announced two key appointments aimed at advancing the company’s future strategy and execution. Christian Uhrich, […]
Stephen MacMillan to retire from the Board SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced changes to its Board of Directors. Scott Gottlieb, MD, has been elected non-executive Chair of Illumina’s Board. Dr. Gottlieb has served on the Board of Directors since 2020. Additionally, Keith Meister, […]
The Board of Atlas Antibodies Group is pleased to announce the appointment of Dan Pitulia as the new Group Chief Executive Officer (CEO). Dan brings a wealth of experience from the life science and healthcare industries, having held leadership roles at e.g. QleanAir, Carmel Pharma and Mölnlycke. Most recently, he served as CEO of Coala […]
Confience, a leading innovator in the Laboratory Information Management System (LIMS) space, is excited to announce the appointment of Jamey Miller as its new Chief Product and Technology Officer. Mr. Miller brings a wealth of industry expertise and leadership experience. Throughout his career, he has held key leadership roles in Engineering, Product Management, Professional Services, […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
